Tyndall Capital Partners L P - Net Worth and Insider Trading

Tyndall Capital Partners L P Net Worth

The estimated net worth of Tyndall Capital Partners L P is at least $9,699 dollars as of 2024-11-13. Tyndall Capital Partners L P is the 10% Owner of Traws Pharma Inc and owns about 1,644 shares of Traws Pharma Inc (TRAW) stock worth over $9,699. Details can be seen in Tyndall Capital Partners L P's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tyndall Capital Partners L P has not made any transactions after 2019-09-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Tyndall Capital Partners L P

To

Tyndall Capital Partners L P Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tyndall Capital Partners L P owns 1 companies in total, including Traws Pharma Inc (TRAW) .

Click here to see the complete history of Tyndall Capital Partners L P’s form 4 insider trades.

Insider Ownership Summary of Tyndall Capital Partners L P

Ticker Comapny Transaction Date Type of Owner
TRAW Traws Pharma Inc 2019-09-24 10 percent owner

Tyndall Capital Partners L P Latest Holdings Summary

Tyndall Capital Partners L P currently owns a total of 1 stock. Tyndall Capital Partners L P owns 1,644 shares of Traws Pharma Inc (TRAW) as of September 24, 2019, with a value of $9,699.

Latest Holdings of Tyndall Capital Partners L P

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRAW Traws Pharma Inc 2019-09-24 1,644 5.90 9,699

Holding Weightings of Tyndall Capital Partners L P


Tyndall Capital Partners L P Form 4 Trading Tracker

According to the SEC Form 4 filings, Tyndall Capital Partners L P has made a total of 0 transactions in Traws Pharma Inc (TRAW) over the past 5 years. The most-recent trade in Traws Pharma Inc is the sale of 45 shares on September 24, 2019, which brought Tyndall Capital Partners L P around $19,873.

Insider Trading History of Tyndall Capital Partners L P

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tyndall Capital Partners L P Trading Performance

GuruFocus tracks the stock performance after each of Tyndall Capital Partners L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tyndall Capital Partners L P is -25.45%. GuruFocus also compares Tyndall Capital Partners L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tyndall Capital Partners L P within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tyndall Capital Partners L P's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tyndall Capital Partners L P

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.75 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.68 LIMIT LIMIT LIMIT LIMIT LIMIT

Tyndall Capital Partners L P Ownership Network

Ownership Network List of Tyndall Capital Partners L P

No Data

Ownership Network Relation of Tyndall Capital Partners L P

Insider Network Chart

Tyndall Capital Partners L P Owned Company Details

What does Traws Pharma Inc do?

Who are the key executives at Traws Pharma Inc?

Tyndall Capital Partners L P is the 10 percent owner of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .

Traws Pharma Inc (TRAW) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Traws Pharma Inc Insider Transactions

No Available Data

Tyndall Capital Partners L P Mailing Address

Above is the net worth, insider trading, and ownership report for Tyndall Capital Partners L P. You might contact Tyndall Capital Partners L P via mailing address: 150 East 58th Street, 14th Floor, New York Ny 10155.